According to Bioventix latest financial reports the cash on hand of BVXP is $7.51M, an decrease of -6.71% to 2022. At the end of 2022 company had $8.05M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $7.51M | -6.71% |
2022 | $8.05M | -5.67% |
2021 | $8.53M | -19.58% |
2020 | $10.61M | 23.54% |
2019 | $8.59M | - |